Neoadjuvant treatment of oesophageal adenocarcinoma

Minerva Chirurgica

Volumn 59, Issue 5, 2004, Pages 461-470

  Robb, W B ^a   Naughton, P ^a   Walsh, T N ^a  

^a Stroke and Hypertension Unit   (Ireland)

Author keywords

Adenocarcinoma; Drug therapy; Esophageal neoplasms, surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; FLUOROURACIL; VASCULOTROPIN; VINBLASTINE; VINDESINE;

ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; RADIATION DOSE; REVIEW; SINGLE DRUG DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; NEOADJUVANT THERAPY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; TREATMENT OUTCOME;

EID: 8544226941     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Devesa S, Blot W, Fraumeni J Jr. Changing patterns of the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;48:2049-53.
3. Pye JK, Crumplin MKH, Charles J, Kerwat R, Foster ME, Biffin A; Hospital clinicians in Wales. One year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg 2001;88:278-85.
4. Lagergren J, Bergstrom R, Lingren A. Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
5. Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histological types of oesophageal cancer in Sweden. Int J Cancer 2002;99:751-4.
6. Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995:222:654-62.
7. Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japenese institutions trial. Jpn J Clin Oncol 1996;26:310-5.
8. O'Sullivan GC, Sheehan D, Clarke, Stuart R, Kelly J, Kiely MD et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999:116:543-8.
9. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57.
10. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002;360:683-9.
11. Baum M, Radwe B. Does surgery influence the natural history of breast cancer? New York: Future Publishing Company; 1994.
12. Oliver RT. Does surgery disseminate or accelerate cancer? Lancet 1995;346:1506-7.
13. Demicheli R, Valagussa P, Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer 2001;85:490-2.
14. Baum M, Chaplain MA, Anderson AR, Douek M, Vaidya JS. Does breast cancer exist in a state of chaos? Eur J Cancer 1999;35:886-91.
15. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T. Surgical adjuvant chemotherapy: results with one short coursee of cyclophosphamide after mastectomy for breast cancer. Cancer 1978;41:2088-98.
16. Sertoli MR, Bruzzi P, Pronzato P, Queirolo P, Amoroso D, Del Mastro L et al. Randomised cooperative study of peri-operative chemotherapy in breast cancer. J Clin Oncol 1995;13:2712-21.
17. Lee SW, Gleason NR, Southall JC, Allendorf JD, Blanco I, Huang EH et al. A serum-soluble factor(s) stimulates tumour growth following laparotomy in a murine model. Surg Endosc 2000;14:490-4.
18. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
19. Lacy Am, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM et al. Laparoscopy-assisted colectomy versus open colectomy for treatmet of non-metastatic colon cancer: a randomised trial. Lancet 2002;359:2224-9.
20. Tyzzer EE. Factors in the production and growth of tumour metastases. J Med Res 1913;28:309-13.
21. Forastiere AA, Heitmiller RF, Lee DJ, Zahurak M, Abrams R, Kleinberg L et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 1997;3:144-52.
22. Stewart JR, Hoff SJ, Johnson DH, Murray MJ, Butler DR, Elkins CC et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993;218:571-6.
23. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG et al. Survival of patients with carcinoma of the esophagus treated with combined modality therapy. J Thorac Cardiovasc Surg 1993;103:749-55.
24. Hoff SJ, Stewart JR, Sawyers JL, Murray MJ, Merrill WH, Adkins RB et al. Preliminary result with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993;56:282-6.
25. Byfield JE. Theoretical basis and clinical applications of 5-flourouracil as a radiosensitiser: an overview. In: Rotman M, Rosenthal CJ, editors. Concomitant continous infusion chemotherapy and radiation. New York: Springer-Verlag; 1991.p.115.
26. Herskovic A, Martz K, Al-sharaf M, Leichman L, Brindle J, Vaitkevicius V et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
27. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow up of a prospective randomised trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
28. Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-20.
29. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996:14:156-63.
30. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993:105:749-55; discussion 755-6.
31. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981:153:690-2.
32. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJ et al. Low dose preoperative radiotherapy for carcinoma of the esophagus: results of a randomised clinical trial. Radiother Oncol 1992;24:108-13.
33. Gignoux M, Roussell A, Paillot B, Gillet M, Schlag P, Favre JP et al. The value of preoperative radiotherapy in oesophageal cancer: results of a saidy of the EORTC. World J Surg 1987;11:426-32.
34. Wang M, Gu ZX, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomised clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325-7.
35. Huang GJ, Gu XZ. Experience with combined preoperative irradiationand surgery for squamous cell carcinoma of the esophagus. In: Wagner G, Zhang YH, editors. Cancer of the liver, esophagus and nasopharnyx. New York, NY: Springer-Verlag; 1987.p.134.
36. Wie W, Xian-Zhi G, Wiebo Y, Huang GJ, Wang LJ, Zhang DW. Randomised clinical trial on trie combination of preoperative irradiation and surgery in the treatment of oesophageal carcinoma: report of 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325-30.
37. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A et al. Preoperative radiotherapy prolongs survival in operative esophageal carcinoma: a randomised, multicentre study of preoperative radiotherapy and chemotherapy. World J Surg 1992;16:1104-10.
38. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomised clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988;96:242-8.
39. Ancona E, Ruol A, Chiarion-Sileni V et al. Studio prospettico randomizzato di chemioterapia neoadiuvante versus sola chirurgien nel cancro operabile (T2-3 ogni N, M0) dell'esofago. Acta Chir Ital 1995:51:308-17.
40. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J et al. Chemotherapy followed by surgery compared with surgery alone for localised esophageal cancer. N Engl J Med 1998;339:1979-84.
41. MRC Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
42. Schlag P. Randomised trial of preoperative chemotherapy for squamous cell cancer of the oesophagus. The Chirurgische Arbeitsgemeinschaft fur Onkologie der Deutchen Gesllschaft fuer Chirurgie Study Group. Arch Surg 1992:127:1446-50.
43. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994;56:191-7.
44. Kok TC, Van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW, for the Rotterdam Esophageal Tumor Study Group. Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a Phase III multicenter randomised trial. Proc Am Soc Clin Oncol 1997;17:984.
45. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. Chemotherapy for carcnoma of the esophagus: a comparison of evidence from meta-analyses of randomised trials and of historical control studies. Ann Oncol 1996;7:355-9.
46. Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomisd controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-9.
47. Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 patterns of care study. J Clin Oncol 2000;18:455-62.
48. Walsh TN, Noonan N, Holywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
49. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomised trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
50. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-3.
51. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D et al. A randomised trial of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the oesophagus. Cancer 1994;73:1779-84.
52. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997;337:l6l-7.
53. Fagerberg J, Stockheld D, Lewensohn R. Combined treatment modalities in esophageal cancer. Should chemotherapy be included? Acta Oncol 1994;33:439-50.
54. Walsh TN, Grannell M, Mansoor S, Kelly A. Neo-adjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. Dis Esophagus 2002;15:121-4.
55. Burmeister BH, Smithers BM, Fitzgerald L, Gebski V, Devitt P, Ackland S et al. A randomised phase III trial of preoperative chemoradiation followed by surgery versus surgery alone for localised resectable cancer of the esophagus. Proc ASCO 2002;21:130a.
56. McDonnell CO, Harmey JH, Bouchier-Hayes DJ, Walsh TN. Effect of multimodality therapy on circulating vascular endotherlial growth factor levels in patients with oesophageal cancer. Br J Surg 2001;88:1105-9.